Ideas
Markets will demand higher Treasury buyback premiums.
The US Treasury's decision to double buybacks for 10 and 30-year notes changes the rules of the game without a market functioning issue to solve, and the market will punish them by demanding much higher premiums.
Fiscal issues and global hikes weaken USD.
The US Treasury is playing games with the market by shifting funding to the short end without reining in the fiscal deficit, while central banks outside the US are moving towards raising rates, making the US dollar the weak link to short.
Buyback intentions are confusing and require explanation.
SK Hynix's decision to use funds previously raised for capex to buy back domestic stock will confuse investors about the company's intentions, requiring careful explanation to see any follow-through after initial gains.
Stronger currencies and lagging performance favor underdogs.
Stronger Asian currencies will help the region's markets, and investors may rotate into lagging underdog markets like Japan, Hong Kong, and China as they look for better value beyond Korea and Taiwan.
Strong cross-region growth supports consistent dividend increases.
AIA is seeing strong double-digit growth in new business, earnings, and cash generation across its portfolio, particularly in mainland China, Hong Kong, and India, supporting consistent dividend growth.
Demand and supply issues drive copper higher.
Increasing demand and short-term supply issues are driving copper prices to record levels, making acquisitions to boost production highly attractive for miners.
Central bank buying and geopolitics support gold.
Central banks are buying gold at the highest levels in a long time, holding more gold than US Treasuries, which combined with geopolitical tensions and inflation, provides a strong outlook for gold prices to reach $5,000-$5,500 an ounce in 12 months.
BYD challenges Japanese incumbents with compelling EVs.
BYD is aggressively entering the brand-loyal Japanese market with a compelling, well-reviewed, and competitively priced EV, putting domestic incumbents on notice.
Australian credit offers better quality and diversification.
Australian investment grade credit offers a far better spread of credit quality and real economy diversification compared to the US, making it attractive even as hyperscalers issue debt there.
AI supercharges drug development for Korean pharma.
The Korean pharmaceutical sector is emerging as an AI play as drug developments get supercharged by artificial intelligence, driving outperformance in names like Samsung Biologics.
Fierce competition and economic weakness pressure Kuaishou.
Kuaishou's net income fell by a third, the weakest in five years, due to fierce competition and weakness in the broader economy, signaling a potential profit reset and near-term pressure.
Price hikes for advanced chips boost profits.
Reports of Samsung raising prices by 10% to 15% for advanced chip-making contracts provide further evidence of their ability to pass on higher prices and generate more profit.
AI innovation drives outperformance in Chinese biotech.
The Chinese biotech sector is starting to outperform as it benefits from innovation driven by the AI space, emerging as a new leader in the Chinese stock market.
Asian currencies are breaking out against USD.
Asian currencies are breaking out to the upside and looking remarkably better vis-a-vis the US dollar, driven by strong export stories and controlled oil moves.
This Bloomberg Markets video, published August 20, 2026,
features Alex Harris, Mark Cranfield, Garth Jones, Lawrie Conway, Reed Stevenson, Amy Xie Patrick, Anthony Stevens, Min Min Low, Denny
discussing TLT, USD, 000660.KS, Hong Kong equities, FXI, EWJ, AIA, COPPER, GLD, 1211.HK, Australian Investment Grade Credit, 207940.KS, XLV, Kuaishou, 005930.KS, Chinese Biotech Sector, USD/KRW, TWD.
14 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Alex Harris,
Mark Cranfield,
Garth Jones,
Lawrie Conway,
Reed Stevenson,
Amy Xie Patrick,
Anthony Stevens,
Min Min Low,
Denny
· Tickers:
TLT,
USD,
000660.KS,
Hong Kong equities,
FXI,
EWJ,
AIA,
COPPER,
GLD,
1211.HK,
Australian Investment Grade Credit,
207940.KS,
XLV,
Kuaishou,
005930.KS,
Chinese Biotech Sector,
USD/KRW,
TWD